MSD-Simcere COO Renaud Sermondade On Expanding To Low-Tier Hospitals In China: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
The COO of MSD-Simcere discusses reaching out to low-tier hospitals in comments that follow a busy month for joint ventures in China with Pfizer/Hisun, Merck/Simcere and AstraZeneca/WuXi each forming partnerships.